top biopharmaceuticals for glp-1 medication 9 Companies Developing Next-Generation Drugs Top 20 Biopharma Companies of

Regional Growth and Demand North America is expected to generate the largest demand during the forecast period in the global glucagon-like peptide-1 agonists market

Tirzepatide acts on two targets in the body, leading to greater initial weight loss, which also may translate to regaining more weight after switching to orforglipron

September 16, 2025

Message your provider anytime follow-ups are free

Pills vs

It is worth noting that in October, AbbVie announced positive results from the head-to-head phase 3 SEQUENCE study, showing non-inferiority compared to Johnson & Johnson's Stelara (predefined non-inferiority margin of 10%)